A. Naseri Jahfari
Please Note
6 records found
1
Improving Remote Cardiovascular Care with Wearable Data
Algorithms, Study Design, and Subject-Specific Adaptation
By assessing how far wearable-based research has progressed toward operational deployment and identify critical shortcomings in real-world utility and generalizability, we confront several major challenges intrinsic to this domain: the medical interpretability of noisy consumer-grade signals, high inter-subject variability, and the inherent complexity of timeseries data that varies with context (e.g., day/night cycles, physical activity).
Our solution strategy is grounded in machine learning techniques that aim to learn robust, transferable representations of physiological data. In particular, we explore contrastive learning, weak supervision, and morphological modeling—such as acceleration-deceleration curve analysis— as tools to extract clinically relevant patterns. These methods are evaluated across both publicly available and proprietary datasets to ensure applicability to diverse populations.
By addressing these challenges, this dissertation advances the case for smartwatches as viable tools for longitudinal, data-efficient cardiovascular monitoring, contributing to a future in which early detection of conditions like atrial fibrillation and heart failure is feasible at scale in everyday settings.
...
By assessing how far wearable-based research has progressed toward operational deployment and identify critical shortcomings in real-world utility and generalizability, we confront several major challenges intrinsic to this domain: the medical interpretability of noisy consumer-grade signals, high inter-subject variability, and the inherent complexity of timeseries data that varies with context (e.g., day/night cycles, physical activity).
Our solution strategy is grounded in machine learning techniques that aim to learn robust, transferable representations of physiological data. In particular, we explore contrastive learning, weak supervision, and morphological modeling—such as acceleration-deceleration curve analysis— as tools to extract clinically relevant patterns. These methods are evaluated across both publicly available and proprietary datasets to ensure applicability to diverse populations.
By addressing these challenges, this dissertation advances the case for smartwatches as viable tools for longitudinal, data-efficient cardiovascular monitoring, contributing to a future in which early detection of conditions like atrial fibrillation and heart failure is feasible at scale in everyday settings.
Data-efficient machine learning methods in the ME-TIME study
Rationale and design of a longitudinal study to detect atrial fibrillation and heart failure from wearables
Background: Smartwatches enable continuous and noninvasive time series monitoring of cardiovascular biomarkers like heart rate (from photoplethysmograms), step counter, skin temperature, et cetera; as such, they have promise in assisting in early detection and prevention of cardiovascular disease. Although these biomarkers may not be directly useful to physicians, a machine learning (ML) model could find clinically relevant patterns. Unfortunately, ML models typically need supervised (ie, annotated) data, and labeling of large amounts of continuous data is very labor intensive. Therefore, ML methods that are data efficient, ie, needing a low number of labels, are required to detect potential clinical value in patterns found in wearable data. Objective: The primary study objective of the ME-TIME (Machine Learning Enabled Time Series Analysis in Medicine) study is to design an ML model that can detect atrial fibrillation (AF) and heart failure (HF) from wearable data in a data-efficient manner. To achieve this, self-supervised and weakly supervised learning techniques are used. Methods: Two hundred subjects (100 reference, 50 AF, and 50 HF) are being invited to participate in wearing a Fitbit fitness tracker for 3 months. Interested volunteers are sent a questionnaire to determine their health, in particular cardiovascular health. Volunteers without any (history of) serious illness are assigned to the reference group. Participants with AF and HF are recruited in the Haga teaching hospital in The Hague, The Netherlands. Results: Enrollment commenced on May 1, 2022, and as of the time of this report, 62 subjects have been included in the study. Preliminary analysis of the data reveals significant inter-subject variability. Notably, we identified heart rate recovery curves and time-delayed correlations between heart rate and step count as potential strong indicators for heart disease. Conclusion: Using self-supervised and multiple-instance learning techniques, we hypothesize that patterns specific to AF and HF can be found in continuous data obtained from smartwatches.
Machine Learning for Cardiovascular Outcomes from Wearable Data
Systematic Review from a Technology Readiness Level Point of View
Background: Wearable technology has the potential to improve cardiovascular health monitoring by using machine learning. Such technology enables remote health monitoring and allows for the diagnosis and prevention of cardiovascular diseases. In addition to the detection of cardiovascular disease, it can exclude this diagnosis in symptomatic patients, thereby preventing unnecessary hospital visits. In addition, early warning systems can aid cardiologists in timely treatment and prevention. Objective: This study aims to systematically assess the literature on detecting and predicting outcomes of patients with cardiovascular diseases by using machine learning with data obtained from wearables to gain insights into the current state, challenges, and limitations of this technology. Methods: We searched PubMed, Scopus, and IEEE Xplore on September 26, 2020, with no restrictions on the publication date and by using keywords such as “wearables,” “machine learning,” and “cardiovascular disease.” Methodologies were categorized and analyzed according to machine learning-based technology readiness levels (TRLs), which score studies on their potential to be deployed in an operational setting from 1 to 9 (most ready). Results: After the removal of duplicates, application of exclusion criteria, and full-text screening, 55 eligible studies were included in the analysis, covering a variety of cardiovascular diseases. We assessed the quality of the included studies and found that none of the studies were integrated into a health care system (TRL<6), prospective phase 2 and phase 3 trials were absent (TRL<7 and 8), and group cross-validation was rarely used. These issues limited these studies' ability to demonstrate the effectiveness of their methodologies. Furthermore, there seemed to be no agreement on the sample size needed to train these studies' models, the size of the observation window used to make predictions, how long participants should be observed, and the type of machine learning model that is suitable for predicting cardiovascular outcomes. Conclusions: Although current studies show the potential of wearables to monitor cardiovascular events, their deployment as a diagnostic or prognostic cardiovascular clinical tool is hampered by the lack of a realistic data set and proper systematic and prospective evaluation.